Hans-Peter Gerber
Chief Tech/Sci/R&D Officer at SUTRO BIOPHARMA, INC.
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jane Chung | F | 53 | 3 years | |
| William Newell | M | 66 | 15 years | |
| Connie Matsui | F | 70 | 5 years | |
| Michael Dybbs | M | 49 | 6 years | |
| Robert DuBridge | M | - |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 8 years |
| Nicki Vasquez | M | 61 | 9 years | |
| Jon Wigginton | M | 62 | 4 years | |
| Heidi Hunter | F | 66 | 3 years | |
| James Panek | M | 71 | 4 years | |
| Henry Heinsohn | M | - | - | |
| Erich Schlick | M | 72 |
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | 4 years |
| Edward Albini | M | 66 | 11 years | |
| Daniel Petree | M | 68 | - | |
| Joseph Lobacki | M | 65 | 7 years | |
| John Freund | M | 70 | 10 years | |
| Linda Fitzpatrick | F | 67 | 16 years | |
| James Scibetta | M | 59 |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | 7 years |
| Ulf Grawunder | M | 59 |
T-CURX GmbH
| 2 years |
| Bertrand Damour | M | - |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | 4 years |
| Anne Borgman | M | 56 | 1 years | |
| Craig Berman | M | - | 4 years | |
| Regina Cheng | F | - | 4 years | |
| Diana Landa | F | - | 4 years | |
| Carlos Lugo | M | - | - | |
| David Pauling | M | - | - | |
| Werner Rubas | M | - | 3 years | |
| Steve Michel | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Nicole Onetto | M | 71 |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | 4 years |
| Patrick Baeuerle | M | 66 |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | - |
| Theo H. Walthie | M | 76 |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | - |
| Brunilda Shtylla | F | 49 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 26 | 83.87% |
| Switzerland | 4 | 12.90% |
| Germany | 1 | 3.23% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hans-Peter Gerber
- Personal Network
